International Perspectives on NTI Generics: How Regulatory Approaches Differ Across Countries
NTI generics require tighter regulatory controls due to their narrow safety margin. This article compares how the FDA, EMA, Canada, Japan, and others regulate these high-risk drugs - and what it means for patient safety and global access.
Read More
